Abstract
Summary
The global Cell Based Assays market size is projected to grow from US$ 2211 million in 2023 to US$ 3305.5 million in 2030; it is expected to grow at a CAGR of 5.9% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Cell Based Assays Industry Forecast” looks at past sales and reviews total world Cell Based Assays sales in 2023, providing a comprehensive analysis by region and market sector of projected Cell Based Assays sales for 2024 through 2030. With Cell Based Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Based Assays industry.
This Insight Report provides a comprehensive analysis of the global Cell Based Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Based Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Based Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Based Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Based Assays.
United States market for Cell Based Assays is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Cell Based Assays is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Cell Based Assays is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Cell Based Assays players cover Thermo Fisher Scientific, Agilent, Merck KGaA, Qiagen and Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Based Assays market by product type, application, key players and key regions and countries.
Segmentation by type
Kits and Reagents
Synthesis Services
Segmentation by application
Research & Academic Institutes
Pharma & Biotech Companies
CROs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Agilent
Merck KGaA
Qiagen
Bio-Rad
Promega
Funakoshi Co., Ltd.
BioVendor
Canopy Biosciences
Genecopoeia
GenoSensor
Takara Bio
Zymo Research
Biocat
LC Sciences
NanoString Technologies
Quanta BioSciences
Phalanx Biotech
FUJIFILM Wako Pure Chemical Corporation
LPI (LP Information)' newest research report, the “Cell Based Assays Industry Forecast” looks at past sales and reviews total world Cell Based Assays sales in 2023, providing a comprehensive analysis by region and market sector of projected Cell Based Assays sales for 2024 through 2030. With Cell Based Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Based Assays industry.
This Insight Report provides a comprehensive analysis of the global Cell Based Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Based Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Based Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Based Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Based Assays.
United States market for Cell Based Assays is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Cell Based Assays is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Cell Based Assays is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Cell Based Assays players cover Thermo Fisher Scientific, Agilent, Merck KGaA, Qiagen and Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Based Assays market by product type, application, key players and key regions and countries.
Segmentation by type
Kits and Reagents
Synthesis Services
Segmentation by application
Research & Academic Institutes
Pharma & Biotech Companies
CROs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Agilent
Merck KGaA
Qiagen
Bio-Rad
Promega
Funakoshi Co., Ltd.
BioVendor
Canopy Biosciences
Genecopoeia
GenoSensor
Takara Bio
Zymo Research
Biocat
LC Sciences
NanoString Technologies
Quanta BioSciences
Phalanx Biotech
FUJIFILM Wako Pure Chemical Corporation
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Based Assays Market Size 2019-2030
2.1.2 Cell Based Assays Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cell Based Assays Segment by Type
2.2.1 Kits and Reagents
2.2.2 Synthesis Services
2.3 Cell Based Assays Market Size by Type
2.3.1 Cell Based Assays Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cell Based Assays Market Size Market Share by Type (2019-2024)
2.4 Cell Based Assays Segment by Application
2.4.1 Research & Academic Institutes
2.4.2 Pharma & Biotech Companies
2.4.3 CROs
2.5 Cell Based Assays Market Size by Application
2.5.1 Cell Based Assays Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cell Based Assays Market Size Market Share by Application (2019-2024)
3 Cell Based Assays Market Size by Player
3.1 Cell Based Assays Market Size Market Share by Players
3.1.1 Global Cell Based Assays Revenue by Players (2019-2024)
3.1.2 Global Cell Based Assays Revenue Market Share by Players (2019-2024)
3.2 Global Cell Based Assays Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Based Assays by Regions
4.1 Cell Based Assays Market Size by Regions (2019-2024)
4.2 Americas Cell Based Assays Market Size Growth (2019-2024)
4.3 APAC Cell Based Assays Market Size Growth (2019-2024)
4.4 Europe Cell Based Assays Market Size Growth (2019-2024)
4.5 Middle East & Africa Cell Based Assays Market Size Growth (2019-2024)
5 Americas
5.1 Americas Cell Based Assays Market Size by Country (2019-2024)
5.2 Americas Cell Based Assays Market Size by Type (2019-2024)
5.3 Americas Cell Based Assays Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Based Assays Market Size by Region (2019-2024)
6.2 APAC Cell Based Assays Market Size by Type (2019-2024)
6.3 APAC Cell Based Assays Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell Based Assays by Country (2019-2024)
7.2 Europe Cell Based Assays Market Size by Type (2019-2024)
7.3 Europe Cell Based Assays Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Based Assays by Region (2019-2024)
8.2 Middle East & Africa Cell Based Assays Market Size by Type (2019-2024)
8.3 Middle East & Africa Cell Based Assays Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell Based Assays Market Forecast
10.1 Global Cell Based Assays Forecast by Regions (2025-2030)
10.1.1 Global Cell Based Assays Forecast by Regions (2025-2030)
10.1.2 Americas Cell Based Assays Forecast
10.1.3 APAC Cell Based Assays Forecast
10.1.4 Europe Cell Based Assays Forecast
10.1.5 Middle East & Africa Cell Based Assays Forecast
10.2 Americas Cell Based Assays Forecast by Country (2025-2030)
10.2.1 United States Cell Based Assays Market Forecast
10.2.2 Canada Cell Based Assays Market Forecast
10.2.3 Mexico Cell Based Assays Market Forecast
10.2.4 Brazil Cell Based Assays Market Forecast
10.3 APAC Cell Based Assays Forecast by Region (2025-2030)
10.3.1 China Cell Based Assays Market Forecast
10.3.2 Japan Cell Based Assays Market Forecast
10.3.3 Korea Cell Based Assays Market Forecast
10.3.4 Southeast Asia Cell Based Assays Market Forecast
10.3.5 India Cell Based Assays Market Forecast
10.3.6 Australia Cell Based Assays Market Forecast
10.4 Europe Cell Based Assays Forecast by Country (2025-2030)
10.4.1 Germany Cell Based Assays Market Forecast
10.4.2 France Cell Based Assays Market Forecast
10.4.3 UK Cell Based Assays Market Forecast
10.4.4 Italy Cell Based Assays Market Forecast
10.4.5 Russia Cell Based Assays Market Forecast
10.5 Middle East & Africa Cell Based Assays Forecast by Region (2025-2030)
10.5.1 Egypt Cell Based Assays Market Forecast
10.5.2 South Africa Cell Based Assays Market Forecast
10.5.3 Israel Cell Based Assays Market Forecast
10.5.4 Turkey Cell Based Assays Market Forecast
10.5.5 GCC Countries Cell Based Assays Market Forecast
10.6 Global Cell Based Assays Forecast by Type (2025-2030)
10.7 Global Cell Based Assays Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Cell Based Assays Product Offered
11.1.3 Thermo Fisher Scientific Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Agilent
11.2.1 Agilent Company Information
11.2.2 Agilent Cell Based Assays Product Offered
11.2.3 Agilent Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Agilent Main Business Overview
11.2.5 Agilent Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Cell Based Assays Product Offered
11.3.3 Merck KGaA Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Qiagen
11.4.1 Qiagen Company Information
11.4.2 Qiagen Cell Based Assays Product Offered
11.4.3 Qiagen Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Qiagen Main Business Overview
11.4.5 Qiagen Latest Developments
11.5 Bio-Rad
11.5.1 Bio-Rad Company Information
11.5.2 Bio-Rad Cell Based Assays Product Offered
11.5.3 Bio-Rad Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bio-Rad Main Business Overview
11.5.5 Bio-Rad Latest Developments
11.6 Promega
11.6.1 Promega Company Information
11.6.2 Promega Cell Based Assays Product Offered
11.6.3 Promega Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Promega Main Business Overview
11.6.5 Promega Latest Developments
11.7 Funakoshi Co., Ltd.
11.7.1 Funakoshi Co., Ltd. Company Information
11.7.2 Funakoshi Co., Ltd. Cell Based Assays Product Offered
11.7.3 Funakoshi Co., Ltd. Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Funakoshi Co., Ltd. Main Business Overview
11.7.5 Funakoshi Co., Ltd. Latest Developments
11.8 BioVendor
11.8.1 BioVendor Company Information
11.8.2 BioVendor Cell Based Assays Product Offered
11.8.3 BioVendor Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BioVendor Main Business Overview
11.8.5 BioVendor Latest Developments
11.9 Canopy Biosciences
11.9.1 Canopy Biosciences Company Information
11.9.2 Canopy Biosciences Cell Based Assays Product Offered
11.9.3 Canopy Biosciences Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Canopy Biosciences Main Business Overview
11.9.5 Canopy Biosciences Latest Developments
11.10 Genecopoeia
11.10.1 Genecopoeia Company Information
11.10.2 Genecopoeia Cell Based Assays Product Offered
11.10.3 Genecopoeia Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Genecopoeia Main Business Overview
11.10.5 Genecopoeia Latest Developments
11.11 GenoSensor
11.11.1 GenoSensor Company Information
11.11.2 GenoSensor Cell Based Assays Product Offered
11.11.3 GenoSensor Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 GenoSensor Main Business Overview
11.11.5 GenoSensor Latest Developments
11.12 Takara Bio
11.12.1 Takara Bio Company Information
11.12.2 Takara Bio Cell Based Assays Product Offered
11.12.3 Takara Bio Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Takara Bio Main Business Overview
11.12.5 Takara Bio Latest Developments
11.13 Zymo Research
11.13.1 Zymo Research Company Information
11.13.2 Zymo Research Cell Based Assays Product Offered
11.13.3 Zymo Research Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Zymo Research Main Business Overview
11.13.5 Zymo Research Latest Developments
11.14 Biocat
11.14.1 Biocat Company Information
11.14.2 Biocat Cell Based Assays Product Offered
11.14.3 Biocat Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Biocat Main Business Overview
11.14.5 Biocat Latest Developments
11.15 LC Sciences
11.15.1 LC Sciences Company Information
11.15.2 LC Sciences Cell Based Assays Product Offered
11.15.3 LC Sciences Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 LC Sciences Main Business Overview
11.15.5 LC Sciences Latest Developments
11.16 NanoString Technologies
11.16.1 NanoString Technologies Company Information
11.16.2 NanoString Technologies Cell Based Assays Product Offered
11.16.3 NanoString Technologies Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 NanoString Technologies Main Business Overview
11.16.5 NanoString Technologies Latest Developments
11.17 Quanta BioSciences
11.17.1 Quanta BioSciences Company Information
11.17.2 Quanta BioSciences Cell Based Assays Product Offered
11.17.3 Quanta BioSciences Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Quanta BioSciences Main Business Overview
11.17.5 Quanta BioSciences Latest Developments
11.18 Phalanx Biotech
11.18.1 Phalanx Biotech Company Information
11.18.2 Phalanx Biotech Cell Based Assays Product Offered
11.18.3 Phalanx Biotech Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Phalanx Biotech Main Business Overview
11.18.5 Phalanx Biotech Latest Developments
11.19 FUJIFILM Wako Pure Chemical Corporation
11.19.1 FUJIFILM Wako Pure Chemical Corporation Company Information
11.19.2 FUJIFILM Wako Pure Chemical Corporation Cell Based Assays Product Offered
11.19.3 FUJIFILM Wako Pure Chemical Corporation Cell Based Assays Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 FUJIFILM Wako Pure Chemical Corporation Main Business Overview
11.19.5 FUJIFILM Wako Pure Chemical Corporation Latest Developments
12 Research Findings and Conclusion